Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lear Corporation stock logo
LEA
Lear
$90.94
-0.4%
$88.42
$73.85
$126.85
$4.87B1.29716,705 shs942,108 shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$79.24
-0.1%
$78.89
$73.31
$134.63
$198.52B0.3813.04 million shs33.83 million shs
Novartis AG stock logo
NVS
Novartis
$115.62
-0.3%
$113.06
$96.06
$120.92
$244.56B0.591.59 million shs2.47 million shs
Zoetis Inc. stock logo
ZTS
Zoetis
$157.26
+1.4%
$159.58
$139.70
$200.33
$69.97B0.942.55 million shs3.30 million shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lear Corporation stock logo
LEA
Lear
0.00%+0.51%+0.57%-3.49%-20.65%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%-2.98%+1.84%-15.19%-38.09%
Novartis AG stock logo
NVS
Novartis
0.00%-3.12%+2.82%+3.13%+10.18%
Zoetis Inc. stock logo
ZTS
Zoetis
0.00%-4.27%-2.99%-3.44%-7.31%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Lear Corporation stock logo
LEA
Lear
4.9407 of 5 stars
3.15.02.50.92.62.54.4
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.997 of 5 stars
3.25.05.03.93.02.53.8
Novartis AG stock logo
NVS
Novartis
1.6844 of 5 stars
1.04.02.50.02.20.01.9
Zoetis Inc. stock logo
ZTS
Zoetis
4.6116 of 5 stars
3.53.04.20.43.52.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lear Corporation stock logo
LEA
Lear
2.23
Hold$107.0917.76% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.43
Hold$109.1937.79% Upside
Novartis AG stock logo
NVS
Novartis
2.00
Hold$123.386.71% Upside
Zoetis Inc. stock logo
ZTS
Zoetis
3.00
Buy$212.1334.89% Upside

Current Analyst Ratings Breakdown

Latest LEA, NVS, ZTS, and MRK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$165.00 ➝ $160.00
6/16/2025
Lear Corporation stock logo
LEA
Lear
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$110.00 ➝ $115.00
5/20/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Cautious
5/19/2025
Lear Corporation stock logo
LEA
Lear
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$125.00 ➝ $115.00
5/19/2025
Lear Corporation stock logo
LEA
Lear
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$89.00 ➝ $100.00
5/14/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$115.00 ➝ $84.00
5/12/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$205.00 ➝ $210.00
5/9/2025
Lear Corporation stock logo
LEA
Lear
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$119.00 ➝ $120.00
5/7/2025
Lear Corporation stock logo
LEA
Lear
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$83.00 ➝ $95.00
5/7/2025
Lear Corporation stock logo
LEA
Lear
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$87.00 ➝ $89.00
5/7/2025
Zoetis Inc. stock logo
ZTS
Zoetis
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$189.00 ➝ $170.00
(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lear Corporation stock logo
LEA
Lear
$23.31B0.21$24.51 per share3.71$84.67 per share1.07
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$64.17B3.10$9.49 per share8.35$18.33 per share4.32
Novartis AG stock logo
NVS
Novartis
$50.32B4.85$10.69 per share10.82$21.59 per share5.36
Zoetis Inc. stock logo
ZTS
Zoetis
$9.26B7.56$7.07 per share22.23$10.57 per share14.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lear Corporation stock logo
LEA
Lear
$506.60M$8.5310.666.070.512.09%14.53%4.81%7/24/2025 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$17.12B$6.8711.538.000.8227.27%43.23%17.11%7/29/2025 (Estimated)
Novartis AG stock logo
NVS
Novartis
$11.94B$6.4018.0713.121.6724.70%39.44%16.43%7/17/2025 (Estimated)
Zoetis Inc. stock logo
ZTS
Zoetis
$2.49B$5.5728.2323.302.6127.12%55.48%19.14%8/5/2025 (Estimated)

Latest LEA, NVS, ZTS, and MRK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/17/2025Q2 2025
Novartis AG stock logo
NVS
Novartis
$2.37N/AN/AN/A$13.94 billionN/A
5/6/2025Q1 2025
Lear Corporation stock logo
LEA
Lear
$2.64$3.12+$0.48$1.49$5.47 billion$5.56 billion
5/6/2025Q1 2025
Zoetis Inc. stock logo
ZTS
Zoetis
$1.40$1.48+$0.08$1.41$2.20 billion$2.22 billion
4/29/2025Q1 2025
Novartis AG stock logo
NVS
Novartis
$2.12$2.28+$0.16$1.83$12.92 billion$13.23 billion
4/24/2025Q1 2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.16$2.22+$0.06$2.01$15.59 billion$15.53 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lear Corporation stock logo
LEA
Lear
$3.083.39%N/A36.11%N/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.244.09%N/A47.16%14 Years
Novartis AG stock logo
NVS
Novartis
$2.602.25%N/A40.63%N/A
Zoetis Inc. stock logo
ZTS
Zoetis
$2.001.27%N/A35.91%14 Years

Latest LEA, NVS, ZTS, and MRK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2025
Zoetis Inc. stock logo
ZTS
Zoetis
quarterly$0.501.2%7/18/20257/18/20259/3/2025
5/27/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.814.18%6/16/20256/16/20257/8/2025
5/16/2025
Lear Corporation stock logo
LEA
Lear
quarterly$0.773.25%6/5/20256/5/20256/25/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lear Corporation stock logo
LEA
Lear
0.57
1.32
1.03
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.69
1.41
1.16
Novartis AG stock logo
NVS
Novartis
0.56
0.79
0.61
Zoetis Inc. stock logo
ZTS
Zoetis
1.12
1.74
1.04

Institutional Ownership

CompanyInstitutional Ownership
Lear Corporation stock logo
LEA
Lear
97.04%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
Novartis AG stock logo
NVS
Novartis
13.12%
Zoetis Inc. stock logo
ZTS
Zoetis
92.80%

Insider Ownership

CompanyInsider Ownership
Lear Corporation stock logo
LEA
Lear
0.91%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.13%
Novartis AG stock logo
NVS
Novartis
0.01%
Zoetis Inc. stock logo
ZTS
Zoetis
0.18%
CompanyEmployeesShares OutstandingFree FloatOptionable
Lear Corporation stock logo
LEA
Lear
173,70053.46 million52.98 millionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.51 billion2.51 billionOptionable
Novartis AG stock logo
NVS
Novartis
75,8832.11 billion2.11 billionOptionable
Zoetis Inc. stock logo
ZTS
Zoetis
13,800445.21 million444.41 millionOptionable

Recent News About These Companies

Stifel Downgrades Zoetis (ZTS)
Top Stock Movers Now: Jabil, Oracle, Zoetis, and More

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Lear stock logo

Lear NYSE:LEA

$90.94 -0.32 (-0.35%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$91.20 +0.27 (+0.29%)
As of 06/20/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lear Corporation designs, develops, engineers, manufactures, assembles, and supplies automotive seating, and electrical distribution systems and related components for automotive original equipment manufacturers in North America, Europe, Africa, Asia, and South America. Its Seating segment offers seat systems, seat subsystems, keyseat components, seat trim covers, seat mechanisms, seat foams, and headrests, as well as surface materials, such as leather and fabric for automobiles and light trucks, compact cars, pick-up trucks, and sport utility vehicles. The company's E-Systems segment provides electrical distribution and connection systems that route electrical signals and networks; and manage electrical power within the vehicle for various powertrains. This segment's products comprise wire harnesses, terminals and connectors, engineered components, and junction boxes; electronic system products, including body domain control modules, smart and passive junction boxes, gateway and communication modules, integrated power modules, and high voltage switching and power control systems. It also offers software and connected services comprising Xevo Market, an in-vehicle commerce and service platform; and software and services for the cloud, vehicles, and mobile devices. In addition, this segment provides cybersecurity software; advanced vehicle positioning for automated and autonomous driving applications; and short-range communication and cellular protocols for vehicle connectivity. It offers its products and services under the XEVO, GUILFORD, EAGLE OTTAWA, ConfigurE+, INTUTM, LEAR CONNEXUSTM, EXO, JOURNEYWARE, ProTec, SMART JUNCTION BOX, STRUCSURE, AVENTINO, and TeXstyle brands. Lear Corporation was founded in 1917 and is headquartered in Southfield, Michigan.

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$79.24 -0.05 (-0.06%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$78.72 -0.53 (-0.67%)
As of 06/20/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Novartis stock logo

Novartis NYSE:NVS

$115.62 -0.34 (-0.29%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$116.65 +1.03 (+0.89%)
As of 06/20/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Zoetis stock logo

Zoetis NYSE:ZTS

$157.26 +2.20 (+1.42%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$157.19 -0.07 (-0.04%)
As of 06/20/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.